TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Published:2013-05-20 Issue:5 Volume:8 Page:e63712
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Maire Virginie,Baldeyron Céline,Richardson Marion,Tesson Bruno,Vincent-Salomon Anne,Gravier Eléonore,Marty-Prouvost Bérengère,De Koning Leanne,Rigaill Guillem,Dumont Aurélie,Gentien David,Barillot Emmanuel,Roman-Roman Sergio,Depil Stéphane,Cruzalegui Francisco,Pierré Alain,Tucker Gordon C.,Dubois Thierry

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference71 articles.

1. Concordance among gene-expression-based predictors for breast cancer;C Fan;N Engl J Med,2006

2. Molecular portraits of human breast tumours;CM Perou;Nature,2000

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;T Sorlie;Proc Natl Acad Sci U S A,2001

4. Repeated observation of breast tumor subtypes in independent gene expression data sets;T Sorlie;Proc Natl Acad Sci U S A,2003

5. Triple-negative breast cancer;WD Foulkes;N Engl J Med,2010

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling key genes in esophageal and lung adenocarcinoma progression: A combined high-throughput analysis and molecular docking approach for targeted therapies;Human Gene;2024-12

2. Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel‐resistant breast cancer cells: An in silico and in vitro study;Chemical Biology & Drug Design;2024-07-29

3. CD8⁺ T cell‑related KCTD5 contributes to malignant progression and unfavorable clinical outcome of patients with triple‑negative breast cancer;Molecular Medicine Reports;2024-07-12

4. Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer;Oncology Reports;2024-06-21

5. Mitotic kinases are emerging therapeutic targets against metastatic breast cancer;Cell Division;2024-06-17